Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,756 across all filing types
Latest filing 2025-10-21 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to the stock exchange listing department, disclosing that the Competition Commission of India has granted approval for a transaction involving the acquisition of a controlling stake. It references previous media releases and stock exchange intimations but does not contain detailed financial data or the full transaction details. The document is a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements, 2015, indicating it is an announcement related to a merger/acquisition approval rather than the full merger filing or detailed report. Given the short length (1534 characters) and the nature of the content, it fits best as a Regulatory Filing (RNS) rather than a full M&A filing or other detailed report.
2025-10-21 English
Announcement under regulation 30 of SEBI LODR
M&A Activity Classification · 95% confidence The document is a short letter addressed to the stock exchange's listing department, disclosing that the Competition Commission of India (CCI) has granted approval for a transaction involving Torrent Pharmaceuticals acquiring a controlling stake in another company. It references previous media releases and stock exchange intimations about the acquisition. The document is a regulatory disclosure under SEBI Listing Obligations and Disclosure Requirements, 2015, specifically about an update on a merger/acquisition approval. The document length is only 1534 characters, indicating it is a brief announcement rather than a detailed report. It does not contain financial statements or detailed analysis, so it is not an Annual Report, Interim Report, or Management Discussion. It is not a full M&A filing but an update on regulatory approval related to M&A activity. According to the filing definitions, announcements related to merger proposals or takeover bids fall under M&A Activity (Code: TAR). Therefore, the correct classification is M&A Activity (TAR). Confidence is high given the clear content and context.
2025-10-21 English
Credit Rating
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange listing department, referencing Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the credit rating reaffirmation and assignment by ICRA Limited for the company's banking facilities, existing and proposed Non-Convertible Debentures, and commercial paper program. The document is an update on credit rating status, which is a form of financial or capital market update but does not contain financial statements or detailed financial results. It is not an earnings release, annual report, or audit report. It is a regulatory disclosure related to credit rating, which fits best under Regulatory Filings (RNS) as it is a compliance announcement and does not fit other more specific categories like Capital/Financing Update (CAP) since it does not announce new financing but rather credit rating information. The document length is short and it is an announcement, not a full report.
2025-10-07 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) regarding the intimation of credit rating. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations for listed entities. The content includes reaffirmation and assignment of credit ratings by ICRA Limited for the company's banking facilities, NCDs, and commercial paper program. The document is short (1811 characters) and serves as an announcement of credit rating updates rather than a detailed financial report or audit. It does not contain financial statements or detailed analysis but is a regulatory disclosure about credit ratings. Therefore, it fits best under Capital/Financing Update (CAP), which covers updates on company financing activities and credit ratings.
2025-10-07 English
Credit Rating- New
Capital/Financing Update Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the intimation of credit rating under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the affirmation and assignment of credit ratings by India Ratings and Research Private Limited. The content is an update on credit rating status, which relates to financing and creditworthiness information. The document is short (1508 characters) and serves as an announcement rather than a detailed report or financial statement. Therefore, it fits best under Capital/Financing Update (CAP) category, which covers updates on company financing activities and credit ratings.
2025-10-07 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is a short letter addressed to the stock exchanges (BSE and NSE) regarding the intimation of credit rating affirmation and assignment by India Ratings and Research Private Limited. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations for listed companies. The content is an update on credit rating status, which is a financing-related announcement. The document length is only 1508 characters, indicating it is a brief announcement rather than a detailed report. There is no financial data or detailed analysis, so it is not an Annual Report, Interim Report, or Earnings Release. It is not a certification or legal proceeding. The best fitting category is Capital/Financing Update (CAP), as it relates to credit rating updates affecting the company's financing profile.
2025-10-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.